Sep. 24 2024
Source Page: Scottish Health Survey: content review outcomes reportFound: department 2 Minor injuries unit 3 NHS 24 4 GP/Family Doctor 5 Nurse at GP surgery
Sep. 18 2024
Source Page: Secretary of State for Health and Social Care's address to IPPRFound: 100,000 infants, aged 0-2, were left waiting more than six hours to be seen in A&E last year Cancer
Sep. 18 2024
Source Page: Service specification: specialist gynaecological cancerFound: Service specification: specialist gynaecological cancer
Sep. 18 2024
Source Page: Service specification: hepato-pancreatic biliary (HPB) – pancreatic and periampullary cancersFound: Makes recommendations for care at each stage in the Service User’s pathway, including: treatment (surgery
Sep. 18 2024
Source Page: Service specification: stereotactic radiosurgery and stereotactic radiotherapy (intracranial) (all ages)Found: Accountable Commissioner NHS England – Cancer National Programme of Care (NPOC) NHS commissioning
Sep. 18 2024
Source Page: Service specification: stereotactic radiosurgery and stereotactic radiotherapy (intracranial) (teenage, young adults and adults)Found: Accountable Commissioner NHS England – Cancer National Programme of Care (NPOC) NHS commissioning
Sep. 18 2024
Source Page: Service specification: hepato-pancreatic biliary (HPB) – primary liver, secondary liver, perihilar biliary tract and gallbladder cancersFound: Makes recommendations for care at each stage in the Service User’s pathway, including: treatment (surgery
Sep. 17 2024
Source Page: Health briefing packs ahead of Scottish Parliament health committee: FOI releaseFound: BREAST CANCER ANASTROZOLE Breast Cancer Drug • The National Cancer Medicines Advisory Group
Sep. 17 2024
Source Page: Health Board Funding Allocation: FOI releaseFound: anaesthetics, emergency medicine, general pra ctice, intensive care medicine, paediatrics, psychiatry and surgery
Sep. 17 2024
Source Page: Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancerFound: Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer